Vitamin D3 and Colorectal Cancer

Advances in Experimental Medicine and Biology

Volumn 617, Issue , 2008, Pages 271-280

  Larriba, M J ^a   Valle, N ^a   Alvarez S ^a   Munoz A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; CALCITRIOL; CALCITRIOL DERIVATIVE; COLECALCIFEROL; ESTROGEN; TRANSCRIPTION FACTOR SNAIL; VITAMIN D RECEPTOR; VITAMIN;

ANTINEOPLASTIC ACTIVITY; CELL DEATH; CELL PROLIFERATION; COLORECTAL CANCER; COLORECTAL SURGERY; CONFERENCE PAPER; DIET SUPPLEMENTATION; DRUG EFFECT; HUMAN; LOW DRUG DOSE; MORTALITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; COLORECTAL TUMOR; METABOLISM; PATHOLOGY; REVIEW;

CHOLECALCIFEROL; COLORECTAL NEOPLASMS; HUMANS; VITAMINS;

EID: 46749137532     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-69080-3_25     Document Type: Conference Paper

References (32)

1. Sancho E, Batlle E, Clevers H (2004) Signaling pathways in intestinal development and cancer. Annu Rev Cell Dev Biol 20:695-723.
2. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61:759-767.
3. Gregorieff A, Clevers H (2005) Wnt signaling in the intestinal epithelium: from endoderm to cancer. Genes Dev 19:877-890.
4. Sutton ALM, MacDonald PN (2003) Vitamin D: more than a "bone-a-fide" hormone. Mol Endocrinol 17:777-791.
5. Ordóñez-Morán P, Larriba MJ, Pendás-Franco N, et al. (2005) Vitamin D and cancer: an update of in vitro and in vivo data. Front Biosci 10:2723-2749.
6. Garland CF, Garland FC, Gorham ED, et al (2006) The role of vitamin D in cancer prevention. Am J Public Health 96:252-261.
7. min mouse. Cancer Res 62:741-746.
8. Pálmer HG, Larriba MJ, García JM, et al. (2004) The transcription factor SNAIL represses vitamin D receptor expression and responsiveness in human colon cancer. Nat Med 10:917-919.
9. 3 receptor. Nucleic Acids Res 34:543-554.
10. KIP1 in vitamin D analog-treated cancer cells. Endocrinology 144:749-753.
11. Kip1 by the VDR/Sp1 complex. J Cell Biochem 98(6):1450-1456.
12. Fernández-García NI, Pálmer HG, García M, et al (2005) 1α,25-Dihydroxyvitamin D3 regulates the expression of Id1 and Id2 genes and the angiogenic phenotype of human colon carcinoma cells. Oncogene 24:6533-6544.
13. Tong W-M, Hofer H, Ellinger A, et al. (1999) Mechanism of antimitogenic action of vitamin D in human colon carcinoma cells: relevance for suppression of epidermal growth factorstimulated cell growth. Oncol Res 11:77-84.
14. González-Sancho JM, Larriba MJ, Ordónez-Morán P, et al (2006) Effects of 1α,25- dihydroxyvitamin D3 in human colon cancer cells. Anticancer Res 26:2669-2682.
15. Oh YS, Kim EJ, Schaffer BS, et al. (2001) Synthetic low-calcaemic vitamin D3 analogues inhibit secretion of insulin-like growth factor II and stimulate production of insulin-like growth factor-binding protein-6 in conjunction with growth suppression of HT-29 colon cancer cells. Mol Cell Endocrinol 183:141-149.
16. Chen A, Davis BH, Sitrin MD, et al. (2002) Transforming growth factor-β?1 signaling contributes to Caco-2 cell growth inhibition induced by 1,25(OH)2D3. Am J Physiol Gastrointest Liver Physiol 283:G864-G874.
17. Yanagisawa J, Yanagi Y, Masuhiro Y, et al. (1999) Convergence of transforming growth factor-β?and vitamin D signaling pathways on SMAD transcriptional coactivators. Science 283:1317-1321.
18. 3 promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of β-catenin signaling. J Cell Biol 154:369-387.
19. 3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy. Cancer Res 60:2304-2312.
20. 3 in human colon cancer cells. Cancer Res 63:7799-7806.
21. Makishima M, Lu TT, Xie W, et al. (2002) Vitamin D receptor as an intestinal bile acid sensor. Science 296:1313-1316.
22. Banwell CM, MacCartney DP, Guy M, et al. (2006) Altered nuclear receptor corepressor expression attenuates vitamin D receptor signaling in breast cancer cells. Clin Cancer Res 12:2004-2013.
23. 3-relevance for colonic cancer prevention and therapy. Mol Aspects Med 24:459-465.
24. Esteban LM, Eisman JA, Gardiner EM (2005) Vitamin D receptor promoter and regulation of receptor expression. In: Feldman D, Pike JW, Glorieux FH (eds.). Vitamin D. Burlington: Elsevier Academic Press, pp. 1571-1597.
25. Barrallo-Gimeno A, Nieto MA (2005) The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development 132:3151-3161.
26. Peña C, García JM, Silva J, et al. (2005) E-cadherin and vitamin D receptor regulation by SNAIL and ZEB1 in colon cancer: clinicopathological correlations. Hum Mol Genet 14:3361-3370.
27. Larriba MJ, Muñoz A (2005) SNAIL vs vitamin D receptor expression in colon cancer: therapeutics implications. Br J Cancer 92:985-989.
28. Kommagani R, Caserta TM, Kadakia MP (2006) Identification of vitamin D receptor as a target of p63. Oncogene 25:3745-3751.
29. Maruyama R, Aoki F, Toyota M, et al. (2006) Comparative genome analysis identifies the vitamin D receptor gene as a direct target of p53-mediated transcriptional activation. Cancer Res 66:4574-4583.
30. Lechner D, Kállay E, Cross HS (2005) Phytoestrogens and colorectal cancer prevention. Vitam Horm 70:169-198.
31. Gaschott T, Stein J (2003) Short-chain fatty acids and colon cancer cells: the vitamin D receptorbutyrate connection. Recent Results Cancer Res 164:247-257.
32. Schuster I, Egger H, Reddy GS, et al. (2003) Combination of vitamin D metabolites with selective inhibitors of vitamin D metabolism. Recent Results Cancer Res 164:169-188.